Immunovant (IMVT) Earnings Date, Estimates & Call Transcripts → Next-Gen AI is Creating Millionaires Right Now (From InvestorPlace) (Ad) Free IMVT Stock Alerts $26.40 +0.40 (+1.54%) (As of 06/28/2024 08:56 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 8EstimatedActual EPS (May. 29) -$0.52 Missed By -$0.08 Consensus EPS (May. 29) -$0.44 Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIMVT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IMVT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the Markets270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that could be a lot more lucrative.Get the ticker here >>> Immunovant Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.48)($0.42)($0.45)Q2 20245($0.49)($0.41)($0.45)Q3 20244($0.55)($0.45)($0.49)Q4 20244($0.46)($0.37)($0.43)FY 202416($1.98)($1.65)($1.82)Q1 20253($0.57)($0.41)($0.50)Q2 20253($0.54)($0.44)($0.49)Q3 20253($0.54)($0.47)($0.51)Q4 20253($0.57)($0.48)($0.52)FY 202512($2.22)($1.80)($2.02)Q1 20262($0.62)($0.46)($0.54)Q2 20262($0.64)($0.46)($0.55)Q3 20262($0.64)($0.47)($0.56)Q4 20262($0.67)($0.52)($0.60)FY 20268($2.57)($1.91)($2.24)IMVT Earnings Date and InformationImmunovant last announced its quarterly earnings data on May 29th, 2024. The reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.44) by $0.08. Immunovant has generated ($1.90) earnings per share over the last year (($1.90) diluted earnings per share). Earnings for Immunovant are expected to decrease in the coming year, from ($2.11) to ($2.31) per share. Immunovant has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.Read More Immunovant Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/8/2024(Estimated)------- 5/29/2024Q4 2024($0.44)($0.52)($0.08)($0.52)--2/12/2024Q4 2023($0.43)($0.36)+$0.07($0.36)--11/9/2023Q2 2024($0.45)($0.45)-($0.45)--8/10/2023Q1 2024($0.44)($0.47)($0.03)($0.37)--5/22/2023Q1 2023($0.41)($0.46)($0.05)($0.46)--2/3/2023Q3 2023($0.41)($0.49)($0.08)($0.49)--Trump’s arrest is phase one (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now.11/4/2022Q2 2023($0.41)($0.41)-($0.41)--8/5/2022Q1 2023($0.40)($0.35)+$0.05($0.35)--6/8/2022Q4 2022($0.38)($0.41)($0.03)($0.41)--2/4/2022Q3 2022($0.34)($0.36)($0.02)($0.36)--11/5/2021Q3 2021($0.26)($0.35)($0.09)($0.35)--8/9/2021Q2 2021($0.31)($0.31)-($0.31)-- 5/31/2021Q1 2021($0.33)($0.29)+$0.04($0.29)--2/16/2021Q4 2020($0.25)($0.32)($0.07)($0.32)--11/12/2020Q3 2020($0.31)($0.25)+$0.06($0.25)--8/12/2020Q2 2020($0.33)($0.38)($0.05)($0.38)--6/29/2020Q1 2020($0.41)($0.38)+$0.03($0.38)--2/14/2020Q3 2020($0.25)($0.28)($0.03)($0.28)-- Immunovant Earnings - Frequently Asked Questions When is Immunovant's earnings date? Immunovant has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on IMVT's earnings history. Did Immunovant beat their earnings estimates last quarter? In the previous quarter, Immunovant (NASDAQ:IMVT) missed the analysts' consensus estimate of ($0.44) by $0.08 with a reported earnings per share (EPS) of ($0.52). Learn more on analysts' earnings estimate vs. IMVT's actual earnings. How much profit does Immunovant generate each year? Immunovant (NASDAQ:IMVT) has a recorded net income of -$259.34 million. IMVT has generated -$1.90 earnings per share over the last four quarters. What is Immunovant's EPS forecast for next year? Immunovant's earnings are expected to decrease from ($2.11) per share to ($2.31) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Utz Brands Earnings Advantage Solutions Earnings Hyliion Earnings MultiPlan Earnings Fisker Earnings Neurocrine Biosciences Earnings Bio-Techne Earnings Qiagen Earnings Vaxcyte Earnings Repligen Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: BlackBerry Stock: Strong Earnings, Profitability Challenges AheadWalgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts AheadAurora Cannabis Earnings Reveal a Turning Tide for the StockDarden Stock Up After Q4 Earnings Beat, Cautious FY25 OutlookAccenture’s Stock Earnings Reveal an AI-Powered Growth StrategySignet Jewelers Stock Poised for Rebound After Earnings DropApple Stock All-Time Highs: Can AI Outweigh Earnings Jitters? This page (NASDAQ:IMVT) was last updated on 7/1/2024 by MarketBeat.com Staff From Our Partners270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredYoung billionaire opens the door for millions of AmericansYou can now profit from a catalog of 11 inventions that will likely make their way into millions of U.S. house...Porter & Company | SponsoredWill Biden Be Replaced?There are growing rumors of a possible Joe Biden replacement following his first debate against Donald Trump. ...Stansberry Research | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredFed’s Plan to Control American Bank AccountsFor months I’ve been warning about the federal government’s terrifying new program to control every American’s...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Immunovant, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunovant With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.